Fresenius Kabi Receives 2025 Premier Supplier Legacy Award
LAKE ZURICH, Ill., July 17, 2025--(BUSINESS WIRE)--Fresenius Kabi, part of the global healthcare company Fresenius, and a leading provider of essential medicines and medical technologies, announced today it has received the 2025 Supplier Legacy Award from Premier, Inc., a leading technology-driven healthcare performance improvement company.
This marks the fifth time since 2015 Premier has recognized Fresenius Kabi USA with this award for operational excellence.
Fresenius Kabi was recognized for its long-standing support of Premier members through exceptional local customer service and engagement, value creation through clinical excellence and a commitment to lower costs. Supplier Legacy Award winners are selected by Premier member committees and have a tenure of more than three years as a Premier contracted supplier.
"This award recognizes the commitment to service, innovation and collaboration by thousands of Fresenius Kabi employees from across our company," said Arun Verma, President, Fresenius Kabi Region U.S. and Member of the Executive Leadership Team, Fresenius Kabi AG. "It's especially gratifying to receive this award from a customer whose members make up more than 4,350 U.S. hospitals and health systems."
"Fresenius Kabi supports Premier members by offering products and services that help improve costs, quality and operations – and deliver overall value," said Bruce Radcliff, Senior Vice President of Supply Chain at Premier. "We're honored to recognize Fresenius Kabi as a Supplier Legacy Award recipient."
The Supplier Legacy Award recipients were honored during Premier's annual Breakthroughs Conference & Exhibition (July 15-17, 2025).
Premier has awarded Fresenius Kabi its Supplier Legacy Award in 2015, 2017, 2018, 2021, and now in 2025. In 2024, Premier also awarded Fresenius Kabi its Trailblazer Award, one of Premier's highest honors, recognizing a national Premier-contracted supplier that delivers innovative and scalable methods and technologies to accelerate clinical evidence into real-world practice.
About Fresenius Kabi
As a global health care company, Fresenius Kabi is Committed to Life. The company's products, technologies, and services are used for the therapy and care of patients with critical and chronic conditions. With more than 41,000 employees and present in more than 100 countries, Fresenius Kabi's expansive product portfolio focuses on providing access to high-quality and lifesaving medicines and technologies.
In Biopharma, Fresenius Kabi offers cutting-edge biosimilars for autoimmune diseases and oncology. With leading market positions in Clinical Nutrition, a broad portfolio of enteral and parenteral products makes a distinct difference in patients' nutritional status – notably as the only corporation offering both product groups. In MedTech, the company provides vital infusion pumps, cell and gene therapy devices, disposables, and more. Fresenius Kabi is a global leader in supplying blood collection bags and devices, supporting blood banks and health care facilities worldwide. The company's I.V. Generics and Fluids for infusion therapy help save millions of lives every year, in emergency medicine, surgery, oncology, and intensive care.
Fresenius Kabi takes a holistic approach to health care and uniquely combines experience, expertise, innovation, and dedication – making a difference in the lives of 450 million patients annually. In line with the #FutureFresenius strategy, the company is developing, producing, and selling new products and technologies and aspires to expand its position as a leading global provider of therapies, improve patient care, generate sustainable value for stakeholders – shaping the future of health care.
Fresenius Kabi is an operating company of the Fresenius Group, founded in 1912, along with Helios and Quirónsalud. As ONE team, the companies in the Fresenius Group are committed to providing lifesaving and life-changing health care solutions on a global scale.
For more information, please visit www.fresenius-kabi.com. To learn about U.S. career opportunities at Fresenius Kabi, visit us at www.fresenius-kabi.com/us/join-us and follow us on LinkedIn and Facebook.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250717604175/en/
Contacts
Media contact Matt Kuhn (847) 220-3033matt.kuhn@fresenius-kabi.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
11 minutes ago
- Yahoo
5 Luxury SUVs That Will Have Massive Price Drops Before 2025 Ends
Many luxury SUVs are getting big price cuts as 2025 comes to an end. Dealers have more cars than buyers, and many models are changing or getting replaced. According to Lauren Fix from Car Coach Reports, high prices and slow demand mean better deals for Americans searching for a luxury SUV. Discover More: For You: Rising loan rates and expensive insurance make owning a luxury SUV even harder this year. Electric SUVs have the sharpest price drops, but gas-powered models are not immune, especially those facing a redesign. Waiting until late in the year could help buyers find bigger discounts as dealers try to move outgoing models. Here are five luxury SUVs with the largest price drops expected before the end of 2025. BMW iX The BMW iX is dropping in price quickly as new electric models and tech updates come out. According to Kelley Blue Book, the BMW iX xDrive50 can lose $51,000 in value over five years, keeping only $37,000 of its original price. Dealers are discounting the iX to clear space for new versions and match slow demand from buyers. Fix notes that struggling sales and a high starting price are leading to strong incentives on the iX. Americans shopping for this SUV in late 2025 could see lower prices and special finance offers from dealers. Patience may pay off for those waiting until the model year ends. Check Out: Mercedes-Benz EQE SUV 'Overproduction and weak consumer interest in all-electric luxury SUVs, including the Mercedes-Benz EQE SUV,' Fix said. Large price drops are common as electric SUV demand slows and new features make older models feel outdated. Earlier this year, when Mercedes-Benz rolled out massive discounts on 2025 high-end EVs, the EQE SUV price was slashed by $8,000. Fix added that high lease returns put even more pressure on dealers, making it easier to bargain for a good deal. Many buyers pick newer technology, which means current models are often discounted by the end of the year. With these developments, it'll be smart to watch out for extra incentives, stacked on top of already lowered prices, before 2025 ends. Cadillac Lyriq The Cadillac Lyriq sees regular markdowns, with more cars than buyers available at most dealerships. According to GM Authority, current deals include low-interest loans, cash rebates and lease offers with extra perks. Buyers can find a $2,000 incentive if they own a vehicle from another luxury brand, plus loyalty bonuses from Cadillac. Fix points out that Cadillac is lowering prices to keep up with new, cheaper rivals offering longer range. As a result, late 2025 could bring even deeper discounts for those ready to buy or lease. Big rebates and extra cash back help buyers get more value for a new Lyriq. Audi Q8 e-tron Audi's Q8 e-tron is about to be redesigned, and dealers are eager to sell the current version. According to Kelley Blue Book, it can lose more than $50,000 in value over five years, leaving a resale price of nearly $23,000. This full-size electric SUV is getting marked down as stores look to avoid old inventory stacking up before new versions launch. Fix explains that strong competition from other electric SUVs adds to the downward price pressure. Watch for deep discounts at stores hoping to clear the Q8 e-tron before the next big update. Buyers can use this timing to ask for better deals and incentives. Genesis GV60 The Genesis GV60 is losing value fast because it is less well-known and faces heavy competition. Kelley Blue Book lists cash-back deals, with special bonuses for groups like first responders, college graduates and military members. Dealers have also advertised extra incentives for those choosing a Genesis over other luxury brands. Fix shares many Americans pick more established luxury names, giving power to those willing to make a switch. Newer electric SUVs with better features cause GV60 prices to stay low through deep discounts and rebates. Waiting for year-end clearance could help buyers save even more. More From GOBankingRates Mark Cuban Warns of 'Red Rural Recession' -- 4 States That Could Get Hit Hard Mark Cuban Tells Americans To Stock Up on Consumables as Trump's Tariffs Hit -- Here's What To Buy Clever Ways To Save Money That Actually Work in 2025 This article originally appeared on 5 Luxury SUVs That Will Have Massive Price Drops Before 2025 Ends
Yahoo
11 minutes ago
- Yahoo
I Asked ChatGTP What Trump's China Deal Means for the Middle Class — Here's What It Said
Rapidly shifting pieces have been synonymous with President Trump's trade policy — China included, according to AP News. Chinese producers sell more than $400 billion worth of goods in the U.S. annually, per Reuters. In order to help orient ourselves within all the changes right now, here's what ChatGTP said President Trump's latest deal with China means for middle-class finances. Check Out: For You: Tariff Reductions Are Partial, Short-Term Relief Tariffs aren't gone, but middle-class households face partial relief because of tariff reductions. A deal slashed U.S. tariffs on Chinese goods from 145% to 30%, according to Time Magazine. However, an average American family would still face a net hike of $2,300 to $2,800 a year in additional tariff-related costs. Trending Now: Consumer Prices Are Still Elevated Consumers continue to pay higher for everyday items, including electronics, clothing and appliances due to residual tariff burdens. Tariffs work like regressive taxes with those in the middle-class paying a larger share of income, per Bloomberg. Inflation and Reduced Purchasing Power Consumer Price Index (CPI) increases tied to tariffs could hit 1.3% to 2.3%, depending on whether all planned tariffs take effect, per Barron's. This is equivalent to a loss of $1,900 to $3,800 in real purchasing power per household annually. Uncertainty Hinders Business and Hiring Amidst pronounced uncertainty, businesses and consumers alike may be less inclined to make big changes or commitment. 'The stop-start nature of tariff implementation slows corporate investment, especially in manufacturing — limiting job growth and wage pressure. Consumer confidence can waver amid this uncertainty,' ChatGPT said. Risk of Retaliation and Spillover Any potential repercussions don't end just because tariffs end. Chinese retaliatory tariffs on U.S. exports could hit middle-class related industries, including autos, agriculture and manufacturing, leading to layoffs or price hikes. 'Ongoing tit-for-tat risks mean future prices and employment could shift again,' ChatGPT explained. So, What Are Your Next Moves? ChatGPT had four suggestions for what to do right now: Budget for inflation in your essential expenses, including groceries, clothes and electronics. Lock in rates for mortgage and loans sooner rather than later as uncertainty may affect financial markets. Track CPI and Fed signals. These reflect tariff-driven inflation trends. Diversify income streams to guard against local job or wage hits. Editor's note on political coverage: GOBankingRates is nonpartisan and strives to cover all aspects of the economy objectively and present balanced reports on politically focused finance stories. You can find more coverage of this topic on More From GOBankingRates Mark Cuban Warns of 'Red Rural Recession' -- 4 States That Could Get Hit Hard 7 Tax Loopholes the Rich Use To Pay Less and Build More Wealth 5 Cities You Need To Consider If You're Retiring in 2025 This article originally appeared on I Asked ChatGTP What Trump's China Deal Means for the Middle Class — Here's What It Said Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
11 minutes ago
- Yahoo
Investors in Monolithic Power Systems (NASDAQ:MPWR) have seen strong returns of 180% over the past five years
When you buy a stock there is always a possibility that it could drop 100%. But on the bright side, you can make far more than 100% on a really good stock. Long term Monolithic Power Systems, Inc. (NASDAQ:MPWR) shareholders would be well aware of this, since the stock is up 170% in five years. It's also good to see the share price up 22% over the last quarter. But this could be related to the strong market, which is up 16% in the last three months. So let's investigate and see if the longer term performance of the company has been in line with the underlying business' progress. Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit. To paraphrase Benjamin Graham: Over the short term the market is a voting machine, but over the long term it's a weighing machine. One way to examine how market sentiment has changed over time is to look at the interaction between a company's share price and its earnings per share (EPS). During five years of share price growth, Monolithic Power Systems achieved compound earnings per share (EPS) growth of 70% per year. This EPS growth is higher than the 22% average annual increase in the share price. So one could conclude that the broader market has become more cautious towards the stock. The company's earnings per share (over time) is depicted in the image below (click to see the exact numbers). We know that Monolithic Power Systems has improved its bottom line over the last three years, but what does the future have in store? Take a more thorough look at Monolithic Power Systems' financial health with this free report on its balance sheet. What About Dividends? It is important to consider the total shareholder return, as well as the share price return, for any given stock. The TSR is a return calculation that accounts for the value of cash dividends (assuming that any dividend received was reinvested) and the calculated value of any discounted capital raisings and spin-offs. Arguably, the TSR gives a more comprehensive picture of the return generated by a stock. As it happens, Monolithic Power Systems' TSR for the last 5 years was 180%, which exceeds the share price return mentioned earlier. This is largely a result of its dividend payments! A Different Perspective While the broader market gained around 19% in the last year, Monolithic Power Systems shareholders lost 12% (even including dividends). Even the share prices of good stocks drop sometimes, but we want to see improvements in the fundamental metrics of a business, before getting too interested. On the bright side, long term shareholders have made money, with a gain of 23% per year over half a decade. It could be that the recent sell-off is an opportunity, so it may be worth checking the fundamental data for signs of a long term growth trend. While it is well worth considering the different impacts that market conditions can have on the share price, there are other factors that are even more important. Even so, be aware that Monolithic Power Systems is showing 3 warning signs in our investment analysis , and 2 of those don't sit too well with us... We will like Monolithic Power Systems better if we see some big insider buys. While we wait, check out this free list of undervalued stocks (mostly small caps) with considerable, recent, insider buying. Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on American exchanges. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
